Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v18-EN Version v17-FR
Language English French
Date Updated 2020-04-22 2020-01-06
Drug Identification Number 02388987 02388987
Brand name LOSARTAN HCT LOSARTAN HCT
Common or Proper name LOSARTAN HCT LOSARTAN HCT
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 25MG 100MG 25MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2019-07-01 2019-07-01
Actual start date 2019-12-31 2019-12-31
Estimated end date Unknown Unknown
Actual end date 2020-04-22
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments